当前位置：首页 > 文献互助 > 互助详情

Hydroxychloroquine for prevention of recurrent miscarriage in France (BBQ): a prospective, multicentre, randomised, placebo-controlled, double-blind, phase 3 trial复制

用户bYXunN-iXvoM 51分钟前 29 10 求助中 帖子自动结束时间: 2026-09-13 17:39:02

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/S3050-5038(25)00207-9复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S3050503825002079复制

其他信息:

出版社: Elsevier BV
作者: Elisabeth Pasquier; Luc de Saint-Martin; Gisèle Marhic; Grégoire Le Gal; Aurélien Delluc; Céline Pimentel; Arsène Mékinian; Céline Chauleur; Geneviève Plu-Bureau; Caroline Bohec; Florence Bretelle; Norbert Winer; Vincent Poindron; Virginie Cogulet; Francis Couturaud; Dominique Mottier; Véronique Debarge; Véronique Lejeune-Saada; Nathalie Lesavre; Tiphaine Raia-Barjat; Charles Bellot; Gaelle Le Foll; Denis Gallot; Franck Mauviel; Pascal Ko-Kivok-Yun; Aurélie Chirol; Guilia Mencattini; Estelle Leclerc; Amélie Fiedler

上一篇：Targeting Human Epidermal Growth Factor Receptor 2 Overexpression in NSCLC With Trastuzumab Deruxtecan—Expectation From DESTINY

互助时间线

2026-09-08 17:39:02 [发起求助]

最新发布的求助

Hydroxychloroquine for prevention of recurrent miscarriage in France (BBQ): a prospective, multicentre, randomised, placebo-controlled, double-blind, phase 3 trial 51分钟前
Targeting Human Epidermal Growth Factor Receptor 2 Overexpression in NSCLC With Trastuzumab Deruxtecan—Expectation From DESTINY 1小时前
Dapagliflozin as an Adjunct to Insulin Improves Time-in-Range and Glycemic Variability versus Acarbose in Adults With Type 1 Diabetes: A Randomized Crossover Trial 1小时前
https://doi.org/10.1063/1.3499306 1小时前
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial 1小时前
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial 1小时前
Redox‐Neutral Vicinal Dialkylation of Aryl Boronic Esters via the Palladium/Norbornene Cooperative Catalysis 1小时前
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer 1小时前
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial 1小时前
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study 1小时前
New and Practical Synthesis of N-(Pyrimidin-5-ylmethyl)pyridin-2-amine, the Key Intermediate to Triflumezopyrim 1小时前
6PPD-Q: A comprehensive critical review on environmental occurrence, toxicological mechanisms, risk assessment, and mitigating strategies 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com